Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

VWXY20_ACCIDENTAL_POISO_EXPOS_ORGANIC_SOLVE_HALOGENA_HYDROCA_THEIR_VAPOU

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — X46 Cause of death: ICD-10 — X46 2 out of 7 registries used, show all original rules.	88
4. Check minimum number of events None	88
5. Include endpoints None	88
6. Filter based on genotype QC (FinnGen only)	88

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 5
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: X40-X49

NAME	VWXY20_ACCIDENTAL_POISO_EXPOS_ORGANIC_SOLVE_HALOGENA_HYDROCA_THEIR_VAPOU
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	X46
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	X46
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	88	33	55
Unadjusted period prevalence (%)	0.02	0.01	0.02
Median age at first event (years)	47.10	41.32	50.57

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
80: Matched controls
800

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

X46

ICD-10 Finland

Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

+∞

115.1

T36

ICD-10 Finland

Poisoning by systemic antibiotics

11.7

9.3

N05AH04

ATC

quetiapine; oral

5.6

9.1

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

12.0

8.5

T52.9

ICD-10 Finland

Toxic effect: Organic solvent, unspecified

75.6

6.5

T26.6

ICD-10 Finland

Corrosion of cornea and conjunctival sac

75.6

6.5

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3011288) Drugs identified in Urine by Screen method

5.98

7.24

6.8

2.0

—

(3016879) Cocaine [Presence] in Urine

5.03

7.12

5.9

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

5.45

6.98

2.8

1.4

—

(3028300) Cannabinoids [Presence] in Urine

4.55

6.33

5.9

1.4

—

(3027008) Opiates [Presence] in Urine

4.55

6.33

5.9

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

4.44

6.15

5.9

1.4

—

(3027944) Amphetamines [Presence] in Urine

4.12

5.33

6.3

1.4

—

(3023368) Bacteria identified in Blood by Culture

177

2.50

3.98

5.0

4.5

—

(3028707) Methadone [Presence] in Urine by Screen method

6.13

3.77

5.3

1.6

—

(3019150) Specific gravity of Urine by Refractometry

144

2.39

3.28

6.8

3.5

1.01

1.02

kg/l

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

3.41

2.15

1.1

2.1

—

(3044290) Cell count panel - Cerebral spinal fluid

4.21

2.07

1.3

1.9

—

(3003396) Base excess in Arterial blood by calculation

2.37

2.01

4.8

6.7

3.32

1.07

mmol/l

1.43

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2.37

2.01

4.8

6.4

5.22

5.12

kpa

0.20

(4010399)

2.59

1.94

1.1

1.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2.93

1.84

6.9

7.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

3.72

1.64

1.8

1.5

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2.32

1.58

1.0

1.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2.16

1.46

1.3

2.2

0.19

0.24

g/l

0.93

(40768443) Skin Pathology biopsy report

2.85

1.46

1.3

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

3.25

1.46

1.4

3.74

3.69

mmol/l

—

(3019060) Gas panel - Arterial blood

2.27

1.38

2.6

3.6

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

3.05

1.38

1.4

1.0

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

3.05

1.38

1.4

1.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

100

1.87

1.35

2.0

2.3

—

(3015736) pH of Urine

254

1.63

1.35

5.3

3.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

0.00

1.19

0.0

1.3

—

(3012544) pH of Venous blood

2.02

1.18

2.8

5.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

113

1.75

1.17

2.0

2.5

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

2.59

1.16

2.4

2.5

10.14

10.36

mg/l

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2.45

1.15

1.6

1.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.82

1.09

2.1

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.83

1.06

1.5

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.83

1.06

1.5

1.7

—

(40768797) Stomach Pathology biopsy report

1.79

1.05

1.0

1.3

—

(3019198) Lymphocytes [#/volume] in Blood

363

1.49

1.03

5.3

6.0

1.90

1.78

e9/l

0.55

331

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

261

1.49

0.98

3.0

3.7

26.11

43.69

ng/l

0.60

173

(3008898) HLA-B27 [Presence]

0.00

0.97

0.0

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

145

1.59

0.96

1.5

1.6

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

137

1.60

0.95

1.6

1.9

2.80

3.34

mg/l

0.45

120

(36304419) Bacteria [Presence] in Urine

181

1.53

0.94

2.9

2.7

—

(42870588) Differential panel, method unspecified - Blood

228

1.48

0.90

5.7

5.9

—

(3009542) Hematocrit [Volume Fraction] of Blood

683

1.66

0.89

18.9

12.8

38.58

41.12

0.85

548

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.81

0.85

1.4

1.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

0.49

0.84

1.4

1.3

—

5.20

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.73

0.79

3.3

3.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

319

1.40

0.77

5.1

3.9

—

(3049717) Cytology report of Urine Cyto stain

2.24

0.77

2.2

2.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

2.24

0.77

1.4

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

2.15

0.76

1.6

3.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

110

1.56

0.75

3.8

3.0

1100.91

32.12

ng/l

0.46

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

154

1.48

0.74

1.6

1.3

0.70

1.20

u/ml

—

(3019832) Treponema pallidum Ab [Presence] in Serum

102

1.57

0.73

1.5

1.8

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

177

0.63

0.73

3.2

2.8

0.49

0.80

ug/l

—

106

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

237

1.40

0.72

2.6

2.9

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1.90

0.69

4.8

2.7

39.20

49.14

u/l

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

104

1.53

0.68

3.1

2.6

1.25

1.77

e6/l

—

(3000494) Fungus identified in Specimen by Culture

1.60

0.66

1.2

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.63

0.65

1.4

1.6

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1.77

0.65

2.2

1.7

42.20

39.93

nmol/l

—

(21494755) Public health laboratory ask at order entry panel

113

0.59

0.63

1.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

720

1.56

0.63

18.3

12.4

21.36

21.67

mg/l

0.04

564

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

106

1.50

0.63

3.1

2.5

1.48

0.71

e6/l

—

(3037121) Protein [Mass/volume] in Urine

0.00

0.61

0.0

3.1

—

0.20

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

0.00

0.61

0.0

1.8

—

90.45

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.61

0.0

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

0.00

0.61

0.0

1.8

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.60

0.0

1.8

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1.62

0.55

1.0

3.0

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

266

1.32

0.54

4.4

3.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1.45

0.53

3.0

1.9

401.33

378.75

nmol/l

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

240

1.31

0.50

1.8

97.91

91.33

pmol/l

0.32

123

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1.60

0.50

1.0

1.2

—

17.36

—

(3022621) pH of Urine by Test strip

1.53

0.49

7.9

2.0

—

(3025159) Blasts/100 leukocytes in Blood

1.50

0.48

2.3

5.7

—

0.50

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

407

1.27

0.48

9.2

10.7

4.16

4.08

e9/l

0.10

357

(3035350) Ketones [Presence] in Urine by Test strip

339

1.27

0.46

4.6

3.2

0.00

estimate

—

(3021601) Nitrite [Presence] in Urine by Test strip

339

1.27

0.46

6.5

4.4

0.00

estimate

—

(3021440) Promyelocytes/100 leukocytes in Blood

1.43

0.46

2.3

5.5

—

0.35

—

(3002582) Erythrocytes [#/volume] in Urine

206

1.30

0.45

2.9

2.8

12.54

22.25

e6/l

0.65

166

(3000991) Gas panel - Venous blood

1.50

0.44

7.0

8.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.50

0.44

2.6

2.7

—

(40760892) CBC W Ordered Manual Differential panel - Blood

160

1.32

0.43

2.3

5.9

—

(3019225) pH of Specimen

1.42

0.43

3.6

4.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

0.00

0.41

0.0

1.3

—

249.14

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.41

0.0

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.8

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

0.00

0.41

0.0

1.3

—

(40760888) Immunoglobulin light chains.free panel - Serum

0.00

0.41

0.0

3.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.5

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.41

0.0

1.9

—

178.63

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.41

0.0

1.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

0.00

0.41

0.0

1.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

0.00

0.41

0.0

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.5

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

0.00

0.41

0.0

2.5

—

4.18

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

0.00

0.41

0.0

3.4

—

56.76

—

(3018095) Leukocytes [#/volume] in Urine

237

1.27

0.41

3.8

3.3

225.73

39.90

e6/l

0.55

171

(3048689) Calprotectin [Mass/mass] in Stool

1.40

0.40

1.4

2.3

183.57

155.31

ug/g

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

0.00

0.40

0.0

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

153

1.31

0.40

3.8

3.5

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1.41

0.39

1.6

3.0

0.27

0.23

e6/l

—

(3003694) ABO and Rh group [Type] in Blood

191

1.28

0.39

1.4

1.5

—

(3022145) Colonoscopy Study observation

1.32

0.38

1.1

1.3

—

(3044640) Blood type and Crossmatch panel - Blood

220

1.26

0.38

2.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

0.63

0.37

15.2

8.6

—

(40758558) Short blood count panel - Blood

173

1.28

0.37

5.2

7.6

—

(3009261) Glucose [Presence] in Urine by Test strip

346

1.23

0.37

4.8

3.3

0.00

estimate

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

109

1.34

0.36

1.5

1.9

—

(3030467) Casts [#/volume] in Urine by Automated count

184

1.26

0.35

3.0

2.8

0.67

0.40

e6/l

0.35

142

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.36

0.34

1.3

1.0

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

674

1.28

0.34

12.0

11.8

87.43

85.89

ml/min/173m2

0.20

551

(46235355) HIV 1 and 2 tests - Meaningful Use set

185

1.25

0.33

2.4

2.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.38

0.32

1.1

1.8

—

(3017732) Neutrophils [#/volume] in Blood

1.35

0.32

2.9

1.9

4.55

4.02

e9/l

—

(3017181) Myelocytes/100 leukocytes in Blood

1.27

0.30

2.4

5.3

—

1.18

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

678

1.24

0.28

3.7

4.0

5.91

5.87

mmol/l

0.11

620

(3019550) Sodium [Moles/volume] in Serum or Plasma

712

1.25

0.25

19.0

14.2

139.22

139.77

mmol/l

1.22

686

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1.37

0.24

9.2

5.2

26.18

24.06

mmol/l

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1.33

0.23

1.6

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

714

1.23

0.23

19.0

14.3

3.99

4.00

mmol/l

0.10

689

(3025941) Bacteria identified in Stool by Culture

1.26

0.23

1.4

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

102

0.76

0.22

3.3

3.1

2.45

2.43

mmol/l

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1.23

0.22

1.4

2.2

—

(3026008) Bacteria identified in Urine by Culture

174

1.19

0.22

3.4

2.7

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1.20

0.22

2.0

6.3

65.20

89.55

ng/l

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.21

0.0

3.7

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.4

—

6.83

—

(3025130) Human papilloma virus identified in Specimen

0.00

0.21

0.0

2.0

—

(40768795) Lymph node Pathology biopsy report

0.00

0.21

0.0

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

0.21

0.0

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

2.4

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

0.00

0.21

0.0

2.6

—

2.78

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

0.21

0.0

1.2

—

(3045424) Erythrocytes [Presence] in Urine

0.00

0.21

0.0

1.0

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

2.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

2.4

—

(3042631) Mycobacterium sp identified in Specimen

0.00

0.21

0.0

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

2.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.5

—

3.40

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

0.21

0.0

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

3.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

2.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

0.00

0.21

0.0

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

0.00

0.21

0.0

1.4

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.27

0.21

2.3

2.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1.24

0.20

2.3

5.5

—

0.40

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

0.00

0.20

0.0

1.3

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1.25

0.20

2.2

7.6

1.20

1.03

mmol/l

0.67

(1761868) Lipid panel - Serum or Plasma

297

0.87

0.19

2.3

2.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

206

1.16

0.18

4.5

2.7

—

(3026361) Erythrocytes [#/volume] in Blood

811

0.85

0.17

25.0

18.6

4.50

4.59

e12/l

0.76

793

(3035941) MCH [Entitic mass]

811

0.85

0.17

24.9

18.5

30.31

30.35

0.08

800

(3000963) Hemoglobin [Mass/volume] in Blood

811

0.85

0.17

25.0

18.7

135.72

138.61

g/l

1.01

800

(3024731) MCV [Entitic volume]

811

0.85

0.17

25.0

18.6

90.55

90.79

0.19

800

(3007461) Platelets [#/volume] in Blood

810

0.86

0.17

25.2

18.7

265.05

245.36

e9/l

1.76

794

(40761511) CBC panel - Blood by Automated count

761

1.22

0.16

16.5

11.7

—

(3037467) Urinalysis macro (dipstick) panel - Urine

475

1.12

0.16

5.7

3.9

—

(3000492) Spirometry study

1.15

0.16

1.3

1.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

160

1.16

0.15

2.7

2.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

229

1.13

0.14

3.2

2.5

66.32

56.09

u/l

0.59

214

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

518

1.11

0.13

4.5

3.3

—

(3042936) Bacteria identified in Isolate by Culture

105

1.17

0.12

2.8

1.6

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.18

0.11

1.6

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

155

0.88

0.10

2.1

1.7

—

(36660697) Celiac disease serology panel - Serum

1.08

0.09

1.0

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

117

1.13

0.08

1.8

1.7

—

(3044889) 12 lead EKG panel

464

1.08

0.08

3.9

3.5

—

(3012516) Albumin [Mass/volume] in Urine

196

1.09

0.08

2.1

3.3

3601.84

107.02

mg/l

0.46

118

(3022217) INR in Platelet poor plasma by Coagulation assay

0.82

0.08

14.0

20.0

—

1.39

—

(3021589) Normoblasts [#/volume] in Blood

295

1.08

0.08

8.0

10.0

0.00

e9/l

0.50

242

(3002256) Pathology report gross observation

1.03

0.07

1.3

1.2

—

(40768804) Tissue Pathology biopsy report

264

0.93

0.07

1.8

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

168

1.09

0.06

1.6

1.7

1.82

1.45

mmol/l

0.93

144

(3029937) Albumin [Presence] in Urine by Test strip

182

0.92

0.06

5.5

3.6

0.00

estimate

—

(3026493) Urate [Moles/volume] in Serum or Plasma

159

1.09

0.05

2.0

3.1

312.12

8389.81

umol/l

0.98

138

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.11

0.04

1.2

1.5

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

101

1.10

0.04

2.3

4.0

0.78

0.82

mmol/l

0.75

(3013512) EKG study

177

0.95

0.01

4.5

3.7

—

(3019309) Folate [Moles/volume] in Red Blood Cells

126

0.94

0.01

1.7

1.6

989.67

1202.13

nmol/l

0.62

(3032080) INR in Blood by Coagulation assay

254

1.03

0.00

7.5

6.6

1.16

1.15

inr

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

233

0.98

0.00

4.9

4.4

23.33

22.32

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

135

1.04

0.00

1.3

1.6

0.97

1.39

mg/l

—

107

(3027231) Wheat IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3003181) Sodium [Moles/volume] in Urine

0.00

0.0

1.6

—

72.38

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.8

—

(4268621)

0.00

0.0

2.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.8

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

0.0

1.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.8

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

0.00

0.0

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.01

0.00

1.8

1.7

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.7

—

(44790048)

0.00

0.0

1.7

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.6

—

(3010813) Leukocytes [#/volume] in Blood

811

0.98

0.00

24.8

18.7

7.39

6.62

e9/l

2.52

791

(3019420) Tryptase [Mass/volume] in Serum or Plasma

0.00

0.0

1.6

—

8.18

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

0.0

1.4

—

34.29

—

(3045142) Bone marrow Pathology biopsy report

0.00

0.0

1.6

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

0.00

0.0

2.0

—

(44790049)

0.00

0.0

1.7

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.00

0.0

1.4

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.00

0.0

2.5

—

(44790047)

0.00

0.0

1.7

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.00

0.0

2.9

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.7

—

(44813793)

0.00

0.0

1.0

—

(4306422)

0.00

0.0

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.0

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

0.00

0.0

2.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

0.84

0.00

1.4

1.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

3.0

—

(3027945) Reticulocytes/100 erythrocytes in Blood

0.92

0.00

1.2

2.4

1.35

1.99

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

0.0

3.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.6

—

(3023419) Bacteria identified in Sputum by Culture

0.00

0.0

1.3

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

0.00

0.0

1.9

—

2.80

—

(40765096) Chromosome analysis panel by Banding

0.00

0.0

1.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

0.0

1.3

—

1242.14

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.1

—

(3010503) CD19 cells [#/volume] in Blood

0.00

0.0

1.6

—

0.14

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

0.0

1.4

—

1.12

—

(3000093) Morphology [Interpretation] in Blood Narrative

0.00

0.0

1.6

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.6

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

0.00

0.0

2.0

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

2.0

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.1

—

(21494434) Karyotype in Bone marrow

0.00

0.0

1.0

—

(4146454)

0.00

0.0

2.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

0.96

0.00

1.4

4.7

1.19

1.22

mmol/l

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

0.00

0.0

2.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.8

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

0.00

0.0

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(40768441) Liver Pathology biopsy report

0.00

0.0

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.0

1.6

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.0

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.0

2.4

—

(3021788) Differential panel - Synovial fluid

0.00

0.0

1.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

3.0

—

(44806118)

0.00

0.0

1.7

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

0.0

2.4

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

0.0

1.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

210

1.00

0.00

2.9

4.1

5.09

14.00

mg/mmol

1.08

126

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

0.00

0.0

1.2

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.2

—

12.88

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

0.0

1.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.00

0.0

1.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.7

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: VWXY20_ACCIDENTAL_POISO_EXPOS_ORGANIC_SOLVE_HALOGENA_HYDROCA_THEIR_VAPOU – Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours (VWXY20_ACCIDENTAL_POISO_EXPOS_ORGANIC_SOLVE_HALOGENA_HYDROCA_THEIR_VAPOU)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints